eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-IMNM-Immunome Inc

Immunome Inc IMNM

‎$‎13.77-0.64(-4.45%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Immunome Inc
Today
Create an eToro account to buy IMNM stock on a secure, user-friendly, multi-asset trading platform.
Buy Immunome Inc
Buy Immunome Inc
Immunome Inc IMNM
Buy IMNM
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
21.33
Based on analysts who covered IMNM

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Immunome Inc News

More about Immunome Inc
Immunome, Inc. is a biopharmaceutical entity engaged in harnessing the human immune system to cure cancer. The company operates at the global level, with a primary focus on leveraging its proprietary technology to treat a wide range of diseases.

Immunome, Inc. operates within the biotechnology sector and aims to generate antibodies against multiple targets. Its significant approach represents a broad attack on cancer, defining its uniqueness in the medical industry.

Keep up to date on the latest share price changes by adding IMNM stock to your eToro watchlist.
VIEW MORE   

IMNM Stock Price Chart

‎35.03‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Immunome Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Immunome Inc share price today is ‎$‎13.77, reflecting a ‎-4.45‎% change over the last 24 hours and ‎17.61‎% over the past week. The current market capitalization of IMNM is ‎$‎1.25B with an average volume in the last three months of 1.17M. The stock has a P/E ratio of -4.67 and a dividend yield of 0%. With the stock’s beta sitting at 1.18
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎1.25B
Day’s Range
i
Shows the high and low prices of the day.
‎$‎13.38 - ‎$‎14.46
52W Range
i
Shows the high and low prices of the last year.
‎$‎5.36 - ‎$‎21.92
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.17M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-4.67
Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎12.59M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎14.41
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-3.09
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.18
What Is Immunome Inc?
Immunome, Inc. is a biopharmaceutical entity engaged in harnessing the human immune system to cure cancer. The company operates at the global level, with a primary focus on leveraging its proprietary technology to treat a wide range of diseases.

Immunome, Inc. operates within the biotechnology sector and aims to generate antibodies against multiple targets. Its significant approach represents a broad attack on cancer, defining its uniqueness in the medical industry.

Keep up to date on the latest share price changes by adding IMNM stock to your eToro watchlist.
CEO
Clay B. Siegall, PhD
Employees
118
Founded
2006
HQ
Bothell, Washington, US
Med Tech
NASDAQ
Get Started

How can I buy Immunome Inc stocks?

To purchase Immunome Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Immunome Inc (IMNM) page and place an order to buy Immunome Inc.
Buy IMNM
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Immunome Inc
Invest in Immunome Inc
Today
Create an eToro account to buy IMNM stock on a secure, user-friendly, multi-asset trading platform.
Get Started

FAQ

The current price of IMNM is ‎$‎13.77.
The average price target for Immunome Inc is ‎$‎21.33. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Immunome Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Immunome Inc is ‎$‎1.25B
Based on 4 analysts offering recommendations for IMNM in the last 3 months, the overall consensus is Strong Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top